Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for pruritus prevention in children with acute severe burns
ACTRN12610000173099Phase 3Not yet recruiting
- Sponsor
- The Children's Hospital at Westmead
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in pruritus (3 arms), sponsored by The Children's Hospital at Westmead. Primary endpoint: Presence of itch during the last week of a four week treatment period. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
gabapentin
03
Conditions
pruritus
Beyond the preview
Go deeper on ACTRN12610000173099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000173099.